Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Circulation
|
March 23, 2005
Long-term serotonin administration induces heart valve disease in rats
Björn I Gustafsson, Karin Tømmerås, Ivar Nordrum, et al.
European Journal of Oral Sciences
|
November 19, 2010
Serotonin and fluoxetine receptors are expressed in enamel organs and LS8 cells and modulate gene expression in LS8 cells
Elisabeth A Riksen, Astrid K Stunes, Anne Kalvik, et al.
Inflammatory Bowel Diseases
|
April 18, 2014
Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease
Ann E Ostvik, Atle vB Granlund, Bjørn I Gustafsson, et al.
Journal of Cellular Biochemistry
|
December 14, 2006
Long-term fluoxetine administration does not result in major changes in bone architecture and strength in growing rats
I Westbroek, J H Waarsing, J P T M van Leeuwen, et al.
BMC Endocrine Disorders
|
May 28, 2011
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
Astrid K Stunes, Irene Westbroek, Björn I Gustafsson, et al.
Scandinavian Journal of Gastroenterology
|
December 18, 2008
Interactions between gastric acid secretagogues and the localization of the gastrin receptor
Helge L Waldum, Per M Kleveland, Eiliv Brenna, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
November 1, 2011
The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretion
A Chin, B Svejda, B I Gustafsson, et al.
Scandinavian Journal of Gastroenterology
|
May 17, 2015
The guanylate cyclase-C signaling pathway is down-regulated in inflammatory bowel disease
Øystein Brenna, Torunn Bruland, Marianne W Furnes, et al.
Journal of Cellular Biochemistry
|
January 13, 2006
Serotonin and fluoxetine modulate bone cell function in vitro
B I Gustafsson, L Thommesen, A K Stunes, et al.
Journal of Cellular Biochemistry
|
December 6, 2005
Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats
Björn I Gustafsson, Irene Westbroek, Jan H Waarsing, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Circulation
|
March 23, 2005
Long-term serotonin administration induces heart valve disease in rats
Björn I Gustafsson, Karin Tømmerås, Ivar Nordrum, et al.
European Journal of Oral Sciences
|
November 19, 2010
Serotonin and fluoxetine receptors are expressed in enamel organs and LS8 cells and modulate gene expression in LS8 cells
Elisabeth A Riksen, Astrid K Stunes, Anne Kalvik, et al.
Inflammatory Bowel Diseases
|
April 18, 2014
Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease
Ann E Ostvik, Atle vB Granlund, Bjørn I Gustafsson, et al.
Journal of Cellular Biochemistry
|
December 14, 2006
Long-term fluoxetine administration does not result in major changes in bone architecture and strength in growing rats
I Westbroek, J H Waarsing, J P T M van Leeuwen, et al.
BMC Endocrine Disorders
|
May 28, 2011
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
Astrid K Stunes, Irene Westbroek, Björn I Gustafsson, et al.
Scandinavian Journal of Gastroenterology
|
December 18, 2008
Interactions between gastric acid secretagogues and the localization of the gastrin receptor
Helge L Waldum, Per M Kleveland, Eiliv Brenna, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
November 1, 2011
The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretion
A Chin, B Svejda, B I Gustafsson, et al.
Scandinavian Journal of Gastroenterology
|
May 17, 2015
The guanylate cyclase-C signaling pathway is down-regulated in inflammatory bowel disease
Øystein Brenna, Torunn Bruland, Marianne W Furnes, et al.
Journal of Cellular Biochemistry
|
January 13, 2006
Serotonin and fluoxetine modulate bone cell function in vitro
B I Gustafsson, L Thommesen, A K Stunes, et al.
Journal of Cellular Biochemistry
|
December 6, 2005
Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats
Björn I Gustafsson, Irene Westbroek, Jan H Waarsing, et al.
Page
of 12